TY  - GEN
AU  - Lazar,Greg A
AU  - Dang,Wei
AU  - Karki,Sher
AU  - Vafa,Omid
AU  - Peng,Judy S
AU  - Hyun,Linus
AU  - Chan,Cheryl
AU  - Chung,Helen S
AU  - Eivazi,Araz
AU  - Yoder,Sean C
AU  - Vielmetter,Jost
AU  - Carmichael,David F
AU  - Hayes,Robert J
AU  - Dahiyat,Bassil I
TI  - Engineered antibody Fc variants with enhanced effector function
SN  - 0027-8424
PY  - 2006///0425
KW  - Alemtuzumab
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - genetics
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antibody Affinity
KW  - Antibody Specificity
KW  - Antibody-Dependent Cell Cytotoxicity
KW  - Antineoplastic Agents
KW  - metabolism
KW  - B-Lymphocytes
KW  - immunology
KW  - Complement System Proteins
KW  - Cytotoxicity, Immunologic
KW  - Genetic Variation
KW  - Humans
KW  - Immunoglobulin Fc Fragments
KW  - In Vitro Techniques
KW  - Lymphocyte Depletion
KW  - Macaca fascicularis
KW  - Protein Engineering
KW  - Receptors, IgG
KW  - Trastuzumab
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1073/pnas.0508123103
ER  -